Key result
Participants homozygous for the AGT T235 variant had significantly diminished renal plasma flow responses to Angiotensin II infusion (P=0.005), an effect further blunted by obesity (P=0.017).
Why the study?
Does the AGT T235 genotype and obesity affect the renal vascular response to infused Angiotensin II in humans?
Population
120 participants aged 18-60 years, including 34 hypertensive individuals off medication, 57 normotensive…
Comparison
Angiotensin II infusion at a mildly pressor dose vs Comparison by AGT genotype and obesity status
Design
Cross-sectional
Authors
Loading...
AGT T235 homozygosity associates with blunted renal Ang II response, worsened by obesity; hypothesis-generating and should not yet change practice.
Cross-Sectional (n=120)
Does the AGT T235 genotype and obesity affect the renal vascular response to infused Angiotensin II in humans?
p-value: p=0.005
The AGT T235 genotype is associated with a blunted renal vascular response to Angiotensin II, an effect exacerbated by obesity, providing a physiological link to essential hypertension.
Hopkins et al. (1996) conducted a cross-sectional in Essential hypertension (n=120). AGT T235 homozygous genotype vs. Other AGT genotypes was evaluated on Renal plasma flow response to Angiotensin II infusion (p=0.005). Participants homozygous for the AGT T235 variant had significantly diminished renal plasma flow responses to Angiotensin II infusion (P=0.005), an effect further blunted by obesity (P=0.017).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: